Vasodilator effects of the endothelin ET(A) receptor selective antagonist BMS-193884 in healthy men

AIMS: A number of endothelin receptor antagonists (ERAs) are currently in clinical development as potential therapies in states characterized by vasoconstriction, such as systemic hypertension. We investigated the haemodynamic effects of locally and systemically active doses of BMS-193884, an endoth...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Dhaun, Neeraj, Strachan, Fiona E, Newby, David E, Johnston, Neil R, Ford, Neville F, Hammett, Janis L, Palmisano, Maria, Webb, David J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Science Inc 2005
Konular:
Pharmacokinetics and Pharmacodynamics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884878/
https://ncbi.nlm.nih.gov/pubmed/16305585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2005.02503.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller